miR-503 Is Involved in the Protective Effect of Phase II Enzyme Inducer (CPDT) in Diabetic Cardiomyopathy via Nrf2/ARE Signaling Pathway

Figure 1

Fasting blood glucose, body weight, and cardiac dysfunction in streptozotocin- (STZ-) induced diabetes and treatment rats; CR: control rats; DR: diabetes rats; TR: treatment rats; (a-b) fasting blood glucose and body weight; (c–f) each weight’s related indicators; : compared with control rats, value < 0.05 was considered to be statistically significant; #: compared with diabetes rats, value < 0.05 was considered to be statistically significant.

(a)

(b)

(c)

(d)

(e)

(f)